# AB Rh-Negative / Rh-Negative: unusual patterns from the international literature <iframe width="100%" height="20" scrolling="no" frameborder="no" allow="autoplay; encrypted-media" src="https://w.soundcloud.com/player/?url=https%3A//api.soundcloud.com/tracks/soundcloud%253Atracks%253A2369632064&color=%23ff5500&inverse=false&auto_play=false&show_user=true"></iframe><div style="font-size: 10px; color: #cccccc;line-break: anywhere;word-break: normal;overflow: hidden;white-space: nowrap;text-overflow: ellipsis; font-family: Interstate,Lucida Grande,Lucida Sans Unicode,Lucida Sans,Garuda,Verdana,Tahoma,sans-serif;font-weight: 100;"><a href="https://soundcloud.com/bryantmcgill" title="Bryant McGill" target="_blank" style="color: #cccccc; text-decoration: none;">Bryant McGill</a> · <a href="https://soundcloud.com/bryantmcgill/the-molecular-complexity-of" title="The Molecular Complexity of the AB Rh-Negative Phenotype" target="_blank" style="color: #cccccc; text-decoration: none;">The Molecular Complexity of the AB Rh-Negative Phenotype</a></div> The strongest result is that **AB Rh-negative is a rare phenotype, but it is not a singular genotype, lineage, or biological category**. “AB” and “Rh-negative” are generated by different genomic systems—the **ABO locus on chromosome 9** and the **RH locus on chromosome 1**—and their conjunction is primarily a statistical intersection. AB-negative constitutes about **1% of current UK donors** but only about **0.5% of the Dutch population**, illustrating how rapidly its frequency changes with population history. More importantly, two people recorded as AB-negative may carry substantially different RHD/RHCE architectures beneath the same eight-type label. ([NHS Blood Donation](https://www.blood.co.uk/why-give-blood/blood-types/?utm_source=chatgpt.com "Blood types - NHS Blood Donation")) <iframe width="560" height="315" src="https://www.youtube.com/embed/rUah4aYSZ5Q?si=lG_xifWfXp8aoLou" title="YouTube video player" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe> ## Rh-negative is genetically plural The conventional concept—Rh-positive means an intact RHD gene and Rh-negative means its absence—is reasonably accurate for many European and West-Eurasian populations, but it becomes increasingly inaccurate outside that reference frame. Basque sequencing found an exceptionally high **RHD-deletion allele frequency of 47.2%**, while a 2024 Saudi study likewise found that most RhD-negative donors carried homozygous complete RHD deletion. Yet population-genetic analysis has not found convincing evidence that positive natural selection drove the European RHD deletion to high frequency; demographic history, isolation, drift, founder effects and possibly unresolved balancing processes remain more defensible explanations. ([PubMed Central (PMC)](https://pmc.ncbi.nlm.nih.gov/articles/PMC6244411/?utm_source=chatgpt.com "Sequence diversity of the Rh blood group system in Basques")) In East Asia, a substantial fraction of people who appear RhD-negative by ordinary serology actually retain an RHD gene producing **extremely low-density D antigen—the DEL phenotype**. Chinese synthesis estimated that approximately **23.3% of serologically RhD-negative people carry a DEL phenotype**, and that **96.7% of Chinese DEL alleles are the Asian-type DEL**, usually associated with the RHD c.1227G>A allele. Thus, almost one-quarter of apparently Rh-negative Chinese patients may be molecularly closer to Rh-positive than to European deletion-type Rh-negative people. Korean and Japanese transfusion literature similarly emphasizes that East-Asian RhD-negative and variant phenotypes are disproportionately produced by point mutations, fusion genes, hybrid RHD–RHCE structures and DEL alleles rather than simple gene absence. ([Springer](https://link.springer.com/article/10.1186/s12967-021-03116-6 "DEL in China: the D antigen among serologic RhD-negative individuals | Journal of Translational Medicine | Springer Nature Link")) African and African-diaspora Rh genetics introduce another architecture: **RHD pseudogenes, partial-D proteins and RHD–RHCE hybrid genes** occur at materially higher frequencies. A person may express some D epitopes but lack others, meaning that they can test weakly positive—or occasionally negative—with one reagent while remaining capable of producing anti-D against the epitopes they lack. A 2025 Belgian ISBT analysis found that conventional short-read and targeted assays left approximately **25% of complex RH cases ambiguous**, concluding that ancestry-informed haplotype analysis and phased long-read sequencing are needed for many hybrid configurations. ([Amegroups](https://cdn.amegroups.cn/journals/vats/files/journals/29/articles/8041/public/8041-PB6-3429-R2.pdf?filename=aob-08-36.pdf&t=1722024193&utm_source=chatgpt.com "RHD molecular analysis—from discovery to next ...")) The first major conclusion is therefore: > **“Rh-negative” is a serological surface description covering several evolutionarily and clinically distinct molecular states: RHD deletion, silent RHD, complete DEL, partial DEL, weak D, RHD pseudogene, RHD–RHCE hybrid and regulatory failure.** ## AB-negative has an unusual transfusion asymmetry AB-negative is scarce as a donor phenotype, but an AB-negative recipient is not restricted exclusively to AB-negative red cells. Because an AB recipient normally lacks anti-A and anti-B, an AB-negative person can generally receive **AB-negative, A-negative, B-negative or O-negative red cells**. Their red cells, conversely, are mainly useful for AB-negative and AB-positive recipients. This creates an operational inversion: **AB-negative is rare in inventory but comparatively flexible on the receiving side**. ([NHS Blood Donation](https://www.blood.co.uk/why-give-blood/blood-types/ab-negative-blood-type/?utm_source=chatgpt.com "AB negative blood type - NHS Blood Donation")) The plasma relationship runs in the opposite direction. AB plasma lacks the naturally occurring anti-A and anti-B antibodies that constrain other plasma groups, making **AB plasma broadly compatible and disproportionately valuable**. French blood services consequently describe the approximately 4% of French people belonging to group AB as rare and valuable universal plasma donors. For an AB-negative donor, the most distinctive medical value may therefore reside in plasma rather than in the narrow recipient range of their red cells. ([Etablissement francais du sang](https://dondesang.efs.sante.fr/sites/default/files/2022-04/D%C3%A9pliant_Plasma_BD_0.pdf?utm_source=chatgpt.com "COMME POUR LE DON DE SANG,")) ## The AB component is evolutionarily more ancient than Rh-negativity The **A/B polymorphism is extraordinarily old**. Comparative primate genomics indicates that A and B allelic classes constitute a **trans-species polymorphism** maintained by balancing selection across humans, gibbons and Old World monkeys for tens of millions of years. In other words, the ancestral distinction underlying AB blood predates modern humans and may predate several primate speciation events. This does not mean that a modern AB person possesses an intact “ancient primate bloodline”; it means that selection repeatedly preserved functionally different glycan-recognition states across deep evolutionary time. ([PubMed](https://pubmed.ncbi.nlm.nih.gov/23091028/?utm_source=chatgpt.com "The ABO blood group is a trans-species polymorphism in primates - PubMed")) The RhD-negative deletion has a different history. Current evidence does not support treating it as an equally ancient, trans-species lineage marker, nor as evidence of Neanderthal, Denisovan, Cro-Magnon or nonhuman ancestry. The interesting evolutionary asymmetry is therefore that **AB combines two deeply conserved ABO glycan programs, while Rh-negativity usually represents a much more population-specific alteration or suppression of one protein antigen system**. ([PubMed Central (PMC)](https://pmc.ncbi.nlm.nih.gov/articles/PMC3378649/?utm_source=chatgpt.com "Evolutionary genetics of the human Rh blood group system - PMC")) ## AB carries a reproducible coagulation signal The most credible systemic physiology associated with AB is not temperament, cognition or personality; it is **hemostatic regulation**. ABO glycans modify the clearance and processing of **von Willebrand factor and factor VIII**. Non-O groups generally maintain higher circulating concentrations than group O, placing AB near the high end of the clotting-factor distribution in many populations. ABO variation explained approximately **15% of measured VWF variation** in one quantitative study. ([PubMed Central (PMC)](https://pmc.ncbi.nlm.nih.gov/articles/PMC4526567/?utm_source=chatgpt.com "Quantitative Influence of ABO Blood Groups on Factor VIII and ...")) A Danish 41-year phenome-wide study of **482,914 patients** found that AB was associated with higher observed incidence of phlebitis and thrombophlebitis, including lower-extremity thrombophlebitis, other venous embolism and thrombosis, and postphlebitic syndrome. Reported incidence-rate ratios were approximately **1.29, 1.31, 1.31 and 1.82**, respectively, relative to the other ABO groups combined. AB was also associated with an IRR of **1.52** for a category of other or unspecified coagulation defects. These are observational population signals—not personal predictions—and the study did not establish that AB-negative behaves differently from AB-positive. ([eLife](https://elifesciences.org/articles/83116 "Associations of ABO and Rhesus D blood groups with phenome-wide disease incidence: A 41-year retrospective cohort study of 482,914 patients | eLife")) This is nevertheless a genuine biological distinction: **AB is not merely a transfusion label; it is a dual glycosylation state affecting proteins, endothelium, epithelial tissues and host–pathogen interfaces throughout the body**. ## Rh proteins are structural machinery, not decorative markers Ordinary RhD-negative people still possess RHCE and the wider Rh membrane complex. The much rarer **Rh-null phenotype**, in which all Rh antigens are absent, demonstrates why this distinction matters. Rh-null red cells exhibit membrane fragility, altered morphology, shortened survival and chronic hemolytic anemia. Japanese researchers have identified Rh-null families carrying mutations in **RHAG**, the gene encoding the Rh-associated glycoprotein required for normal expression and organization of Rh proteins. ([PubMed](https://pubmed.ncbi.nlm.nih.gov/30990901/?utm_source=chatgpt.com "Rh null phenotype caused by a novel RHAG mutation, c. ...")) A 2026 Japanese study used CRISPR/Cas9 to eliminate RHD, RHCE and several other blood-group genes from cultured erythroid precursor cells. The investigators successfully created cells lacking numerous clinically important antigens while retaining broadly normal proliferation and differentiation. Intriguingly, the engineered cultured cells tolerated Rh deletion better than mature circulating Rh-null erythrocytes, possibly because their residual nuclei, cytoskeleton and Band-3 membrane architecture provided compensatory structural support. The work suggests that blood-group proteins can be computationally and genetically decomposed into **compatibility modules**, although mature transfusable cells remain harder to engineer safely. ([J-STAGE](https://www.jstage.jst.go.jp/article/jjtc/72/1/72_94/_pdf "日本輸血細胞治療学会誌第72巻第1号")) ## Precision pregnancy medicine is dismantling the binary label Maternal–fetal Rh incompatibility remains the clearest clinical consequence of genuine RhD negativity, but even here the field is shifting from broad serological classification toward **fetal and maternal RHD genotyping**. Chinese, Korean and Japanese programs are developing multi-exon assays and maternal-cell-free fetal DNA methods to determine whether an apparently Rh-negative mother actually has deletion-type RHD, complete DEL, partial DEL or another variant—and whether her fetus is truly D-positive. ([Lcsxyjy](https://www.lcsxyjy.com/CN/10.3969/j.issn.1671-2587.2025.02.003?utm_source=chatgpt.com "应用孕妇外周血cff-DNA检测胎儿RHD血型基因的方法学研究")) The Chinese DEL analysis estimated that identifying complete DEL could spare thousands of women from unnecessary anti-D immunoglobulin and redirect scarce Rh-negative blood to genuinely deletion-type or immunization-susceptible recipients. It projected that separating Asian-type DEL from true RhD negativity could increase the effective Chinese supply of genuinely needed Rh-negative units by roughly **30%**. Partial DEL remains a different category because people missing particular D epitopes may still form anti-D. ([Springer](https://link.springer.com/article/10.1186/s12967-021-03116-6 "DEL in China: the D antigen among serologic RhD-negative individuals | Journal of Translational Medicine | Springer Nature Link")) The emerging model is therefore no longer **positive versus negative**, but: **antigen density → epitope completeness → molecular allele → immunization potential → clinical context.** ## AB-negative is a particularly interesting substrate for engineered universal blood In 2024, researchers at the Technical University of Denmark and Lund University reported enzyme mixtures derived from the gut bacterium **Akkermansia muciniphila** that efficiently remove A and B glycan structures from red cells. Twenty-four enzymes were evaluated across hundreds of blood samples. Residual immunoreactivity still prevents clinical use, but the work advances the possibility of converting A, B and AB red cells into O-like cells. ([DTU](https://www.dtu.dk/english/newsarchive/2024/04/enzymes-open-new-path-to-universal-donor-blood "Enzymes open new path to universal donor blood")) An **AB RhD-negative red cell is theoretically an especially direct substrate**: it already lacks detectable D, and enzymatic removal of both A and B structures would make it resemble an O RhD-negative cell at the two dominant compatibility systems. That would not make it universally compatible, however, because the International Society of Blood Transfusion now recognizes **48 separate blood-group systems**. The 2024 MAL system and the 2025 PIGZ system containing the GWADA antigen demonstrate that a person labelled AB-negative may still possess—or lack—hundreds of other clinically relevant antigens. ([ISBT](https://www.isbtweb.org/isbt-working-parties/rcibgt.html?utm_source=chatgpt.com "Red Cell Immunogenetics and Blood Group Terminology")) The plausible frontier is therefore not simply “convert AB-negative into O-negative,” but **construct antigen-minimized, genotype-indexed erythrocytes**, preserving essential membrane functions while removing a selected hierarchy of immunogenic structures. Japanese antigen-deletion cells, European bacterial glycosidases, CRISPR antigen conversion and phased long-read RH sequencing are converging on that architecture. ([PubMed Central (PMC)](https://pmc.ncbi.nlm.nih.gov/articles/PMC12138342/?utm_source=chatgpt.com "CRISPR-Cas9-driven antigen conversion of clinically relevant ...")) ## Disease associations: signals exist, but no coherent Rh-negative syndrome has emerged The Danish phenome-wide study found **28 statistically significant RhD associations** across infections, cancers, metabolic conditions, pregnancy complications and other diagnoses. A separate 2024 European cardiac-resynchronization cohort found Rh-negative status associated with better transplant-free survival, with an adjusted hazard ratio of **0.68**. Yet these findings are exploratory: the Danish cohort was retrospective, hospital-selected and vulnerable to survival and ascertainment biases, while the cardiac result came from a specialized heart-failure population. Neither establishes a general protective or harmful Rh-negative physiology. ([eLife](https://elifesciences.org/articles/83116 "Associations of ABO and Rhesus D blood groups with phenome-wide disease incidence: A 41-year retrospective cohort study of 482,914 patients | eLife")) Older Czech work has reported interactions among RhD status, latent _Toxoplasma gondii_, reaction time, self-reported health and psychological variables. These results remain **unresolved**, partly because several originated within a narrow research lineage, use observational or self-reported measures and lack sufficient independent genomic replication. They should be retained as investigational anomalies rather than converted into established Rh-negative traits. ([Frontiers](https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2019.01012/full?utm_source=chatgpt.com "Negative Effects of Latent Toxoplasmosis on Mental Health")) ## Evidentiary verdict **Established:** AB-negative is a rare intersection of two independent blood-group systems; Rh-negative encompasses multiple genetic mechanisms; East-Asian DEL, African hybrid RHD/RHCE and European deletion-type RhD negativity are materially different; AB influences coagulation through VWF/FVIII biology; Rh proteins participate in red-cell membrane integrity; fetal and donor RHD genotyping can materially improve transfusion and pregnancy management. **Strongly indicated:** The eight conventional blood types are becoming an obsolete clinical compression layer. Long-read sequencing, epitope-level classification and ancestry-aware haplotyping will increasingly replace binary Rh status in advanced transfusion medicine. **Plausible frontier:** AB-negative erythrocytes could become useful substrates for enzymatic or genomic conversion into highly compatible antigen-minimized cells, but “universal” compatibility will require engineering beyond ABO and D. **Unresolved:** Population-level associations involving RhD status, infection, cardiovascular outcomes, neurobehavior and immunity. The signals justify replication but do not yet define an Rh-negative constitutional syndrome. **Unsupported:** A distinct alien, supernatural, archaic-human or cognitively superior Rh-negative lineage; blood-type personality systems; direct descent of Rh-negative people from Neanderthals, Denisovans, Cro-Magnons or an external species. The accessible genomic record supports **population-specific recombination, deletion, mutation and demographic history**, not an anomalous species boundary. The deepest scientifically defensible interpretation is that **AB Rh-negative occupies an unusually information-dense intersection**: ancient balancing selection in the ABO glycan system, population-specific restructuring of the RH locus, distinctive coagulation chemistry, reproductive immunology, rare-donor logistics and an emerging pathway toward programmable blood. It is biologically interesting not because it defines a different kind of human, but because it exposes how radically inadequate the familiar eight-box blood taxonomy has become. ## References and Reading ### International nomenclature, databases, and blood-group classification 1. **[ISBT Blood Group Database](https://blooddatabase.isbtweb.org/)** — The authoritative digital registry maintained by the International Society of Blood Transfusion for recognized blood-group systems, genes, antigens, and alleles. This should be treated as the primary reference for current nomenclature rather than older eight-type popular classifications. ([ISBT Blood Group Database](https://blooddatabase.isbtweb.org/?utm_source=chatgpt.com "ISBT Blood Group Database")) 2. **[ISBT Blood Group Database—January 2026 Release](https://blooddatabase.isbtweb.org/release/11)** — The January 2026 database release records **48 blood-group systems, 56 genes, 397 recognized antigens, and 1,971 alleles**, illustrating how little of human blood-group diversity is represented by the familiar ABO-positive/negative taxonomy. ([ISBT Blood Group Database](https://blooddatabase.isbtweb.org/release/11?utm_source=chatgpt.com "Release: January 2026")) 3. **[Table of Blood Group Systems](https://www.isbtweb.org/resource/tableofbloodgroupsystems.html)** — The official ISBT table of genetically defined blood-group systems. It provides the necessary wider context for understanding why AB Rh-negative is not remotely equivalent to a complete immunohematological identity. ([ISBT](https://www.isbtweb.org/resource/tableofbloodgroupsystems.html?utm_source=chatgpt.com "Table of blood group systems")) 4. **[Red Cell Immunogenetics and Blood Group Terminology](https://www.isbtweb.org/isbt-working-parties/rcibgt.html)** — The ISBT working party responsible for recognizing systems, assigning antigen numbers, standardizing allele names, and incorporating newly resolved blood-group loci. ([ISBT](https://www.isbtweb.org/isbt-working-parties/rcibgt.html?utm_source=chatgpt.com "Red Cell Immunogenetics and Blood Group Terminology")) 5. **[Blood Group Terminology](https://www.isbtweb.org/isbt-working-parties/rcibgt/blood-group-terminology.html)** — Defines the distinctions among a blood group, blood-group system, antigen, allele, collection, and blood type. It is particularly useful for avoiding the widespread error of treating “Rh-negative” as a single genotype. ([ISBT](https://www.isbtweb.org/isbt-working-parties/rcibgt/blood-group-terminology.html?utm_source=chatgpt.com "Blood Group Terminology")) --- ### Evolutionary and population genetics of RhD negativity 6. **[Evolutionary Genetics of the Human Rh Blood Group System](https://pmc.ncbi.nlm.nih.gov/articles/PMC3378649/)** — A foundational population-genetic examination of RHD deletion, RHCE variation, geographic differentiation, and proposed evolutionary explanations. It found no simple selective account sufficient to explain the unusual distribution of RhD negativity. ([PubMed Central (PMC)](https://pmc.ncbi.nlm.nih.gov/articles/PMC3378649/?utm_source=chatgpt.com "Evolutionary genetics of the human Rh blood group system")) 7. **[Sequence Diversity of the Rh Blood Group System in Basques](https://pmc.ncbi.nlm.nih.gov/articles/PMC6244411/)** — Molecular study reporting an **RHD-deletion allele frequency of 47.2%** in its Basque sample, among the highest measured frequencies. The study places the pattern within broader northern Iberian and Franco-Cantabrian variation rather than supporting an isolated or nonhuman lineage claim. ([PubMed Central (PMC)](https://pmc.ncbi.nlm.nih.gov/articles/PMC6244411/?utm_source=chatgpt.com "Sequence diversity of the Rh blood group system in Basques")) 8. **[Molecular Background of RhD-Positive and RhD-Negative Phenotypes in the Saudi Population](https://pubmed.ncbi.nlm.nih.gov/39055072/)** — A 2024 Saudi investigation concluding that most tested RhD-negative Saudis carried homozygous complete RHD deletion. This is valuable because it extends deletion-type Rh negativity beyond the conventional northern-European reference population. ([PubMed](https://pubmed.ncbi.nlm.nih.gov/39055072/?utm_source=chatgpt.com "Molecular Background of RhD-positive and RhD-negative ...")) 9. **[Molecular Basis of the RhD-Negative Phenotype in North Indian Blood Donors](https://pmc.ncbi.nlm.nih.gov/articles/PMC9629522/)** — Examines deletion, pseudogene, hybrid, and variant RHD configurations in an Indian donor population, demonstrating that South-Asian RhD negativity cannot simply be inferred from European genotype frequencies. ([PubMed Central (PMC)](https://pmc.ncbi.nlm.nih.gov/articles/PMC9629522/?utm_source=chatgpt.com "Molecular basis of RhD-negative phenotype in North Indian ...")) 10. **[RHD Alleles in the Tunisian Population](https://pmc.ncbi.nlm.nih.gov/articles/PMC3757771/)** — Surveys Tunisian RHD alleles and documents a North-African mixture of deletion-type, variant, and hybrid structures. This is an important bridge between European, sub-Saharan African, and Near Eastern Rh architectures. ([PubMed Central (PMC)](https://pmc.ncbi.nlm.nih.gov/articles/PMC3757771/?utm_source=chatgpt.com "RHD alleles in the Tunisian population - PMC - NIH")) 11. **[Comprehensive Molecular Analysis of Serologically D-Negative and Weak/Partial-D Thai Blood Donors](https://pmc.ncbi.nlm.nih.gov/articles/PMC7036540/)** — Demonstrates the molecular heterogeneity hidden beneath apparently negative or weak serological results in Thailand, including silent, weak, partial, and hybrid alleles. ([PubMed Central (PMC)](https://pmc.ncbi.nlm.nih.gov/articles/PMC7036540/?utm_source=chatgpt.com "Comprehensive Molecular Analysis of Serologically D ... - PMC")) 12. **[Systematic RH Genotyping and Variant Identification in French Donors of African Origin](https://pmc.ncbi.nlm.nih.gov/articles/PMC3934220/)** — A clinically important study of D and RhCE variants among donors of African ancestry in France. It documents why reagent-based classification can fail in populations with partial D, altered RHCE, and hybrid RH haplotypes. ([PubMed Central (PMC)](https://pmc.ncbi.nlm.nih.gov/articles/PMC3934220/?utm_source=chatgpt.com "Systematic RH genotyping and variant identification in French ...")) 13. **[RHD Genotyping of Rh-Negative and Weak-D Phenotype Individuals](https://pmc.ncbi.nlm.nih.gov/articles/PMC8888359/)** — Reviews and tests the mechanisms underlying negative and weak-D results, including deletion, pseudogene, and RHD–RHCE hybrids, with explicit attention to ancestry-associated differences. ([PubMed Central (PMC)](https://pmc.ncbi.nlm.nih.gov/articles/PMC8888359/?utm_source=chatgpt.com "RHD Genotyping of Rh-Negative and Weak D Phenotype ...")) 14. **[Review: The Molecular Basis of Rh Blood Group Phenotypes](https://pmc.ncbi.nlm.nih.gov/articles/PMC9980290/)** — A detailed molecular account of RHD and RHCE variation, including weak D, partial D, altered C/c and E/e expression, recombination, gene conversion, and population-specific alleles. ([PubMed Central (PMC)](https://pmc.ncbi.nlm.nih.gov/articles/PMC9980290/?utm_source=chatgpt.com "Review: the molecular basis of the Rh blood group phenotypes")) 15. **[Molecular Genetics of RH Hybrid Genes: A Genomic Perspective](https://cdn.amegroups.cn/journals/vats/files/journals/29/articles/6842/public/6842-PB8-6279-R2.pdf?filename=aob-08-7.pdf&t=1731460284)** — Explains how the extreme sequence similarity between RHD and RHCE facilitates unequal crossover, exon exchange, microconversion, and hybrid-gene production. These mechanisms are central to understanding why “positive” and “negative” are insufficient molecular categories. ([AmeGroups](https://cdn.amegroups.cn/journals/vats/files/journals/29/articles/6842/public/6842-PB8-6279-R2.pdf?filename=aob-08-7.pdf&t=1731460284&utm_source=chatgpt.com "Hybrids and microconversions in RH genes")) 16. **[From the Investigation of RHD–CE Hybrid Genes to the Prevention of Alloimmunization](https://pmc.ncbi.nlm.nih.gov/articles/PMC10159803/)** — Connects African-ancestry hybrid alleles and partial-D phenotypes with clinically consequential anti-D formation and transfusion strategy. ([PubMed Central (PMC)](https://pmc.ncbi.nlm.nih.gov/articles/PMC10159803/?utm_source=chatgpt.com "From the investigation of RHD-CE hybrid genes to the ... - PMC")) --- ### Long-read sequencing and the collapse of binary Rh classification 17. **[Accurate Long-Read Sequencing Allows Assembly of the Duplicated RHD and RHCE Genes Harboring Variants Relevant to Blood Transfusion](https://pubmed.ncbi.nlm.nih.gov/34968422/)** — A major technical demonstration that long reads can resolve the structurally complex, highly homologous RHD/RHCE region more accurately than conventional short-read or exon-limited testing. ([PubMed](https://pubmed.ncbi.nlm.nih.gov/34968422/?utm_source=chatgpt.com "Accurate long-read sequencing allows assembly of ... - PubMed")) 18. **[RH Genotyping by Next-Generation Sequencing](https://aob.amegroups.org/article/view/8209/html)** — Reviews next-generation sequencing approaches for donor and patient RH typing, including the limitations created by structural variation, paralogous genes, hybrid alleles, and uncertain phase. ([Annals of Blood](https://aob.amegroups.org/article/view/8209/html?utm_source=chatgpt.com "RH genotyping by next-generation sequencing - Annals of Blood")) 19. **[Blood Group Haplotypes and Third-Generation Sequencing](https://www.isbtweb.org/resource/blood-group-haplotypes-and-third-generation-sequencing.html)** — An ISBT 2025 presentation describing enrichment and long-read sequencing of whole blood-group loci to produce phased haplotypes rather than disconnected variant calls. ([ISBT](https://www.isbtweb.org/resource/blood-group-haplotypes-and-third-generation-sequencing.html?utm_source=chatgpt.com "Blood Group Haplotypes and Third Generation Sequencing")) 20. **[Combined RHD and RHCE Sequencing With Long Reads](https://www.blutspendezurich.ch/fileadmin/downloads/Wissenschaft/Publikationen/2025/RHDCEalleles_ISBT2025.pdf)** — A Swiss ISBT 2025 analysis using Oxford Nanopore sequencing to resolve cases that remained unexplained after routine serology and targeted genetic testing. ([Blutspende Zürich](https://www.blutspendezurich.ch/fileadmin/downloads/Wissenschaft/Publikationen/2025/RHDCEalleles_ISBT2025.pdf?utm_source=chatgpt.com "Combined RHD and RHCE sequencing with long reads ...")) 21. **[How Accurate Is RHD Genotyping Using SSP or Exon-Based Next-Generation Sequencing?](https://www.rodekruis.be/storage/dvb/poster-isbt-2025-van-sandt-et-al.pdf)** — Belgian Red Cross analysis showing that limited SNP panels and unphased exon sequencing can miss or misidentify hybrid RH alleles, supporting complete long-read phasing for difficult cases. ([Rode Kruis](https://www.rodekruis.be/storage/dvb/poster-isbt-2025-van-sandt-et-al.pdf?utm_source=chatgpt.com "How accurate is RHD genotyping using SSP or exon- ...")) 22. **[Genotype Analysis to Clarify RhD Variants in Discrepant Serological Samples](https://pmc.ncbi.nlm.nih.gov/articles/PMC10728993/)** — Molecular investigation of hundreds of discrepant samples, finding weak, extremely weak, partial-D, and DEL alleles beneath uncertain serological classifications. ([PubMed Central (PMC)](https://pmc.ncbi.nlm.nih.gov/articles/PMC10728993/?utm_source=chatgpt.com "Genotype analysis to clarify RhD variants in discrepant ... - PMC")) --- ### DEL: the hidden RhD-positive state inside “Rh-negative” populations 23. **[DEL Phenotype](https://pmc.ncbi.nlm.nih.gov/articles/PMC5676463/)** — A foundational review of DEL, in which D-antigen expression is so low that ordinary serology may classify the cells as RhD-negative. It explains the especially high importance of **RHD*DEL1/RHD c.1227G>A** in East Asia. ([PubMed Central (PMC)](https://pmc.ncbi.nlm.nih.gov/articles/PMC5676463/?utm_source=chatgpt.com "DEL phenotype - PMC")) 24. **[DEL in China: The D Antigen Among Serologic RhD-Negative Individuals](https://pmc.ncbi.nlm.nih.gov/articles/PMC8527646/)** — Comprehensive Chinese synthesis reporting DEL frequencies of approximately **16.3%–32.6%** among serologically RhD-negative Han populations and examining clinical implications for blood allocation and pregnancy prophylaxis. ([PubMed Central (PMC)](https://pmc.ncbi.nlm.nih.gov/articles/PMC8527646/?utm_source=chatgpt.com "DEL in China: the D antigen among serologic RhD-negative ...")) 25. **[Molecular Basis of the DEL Phenotype in the Chinese Population](https://pmc.ncbi.nlm.nih.gov/articles/PMC4024116/)** — Finds RHD c.1227G>A to be the predominant allele in its Chinese DEL cohort while also identifying hybrid and other molecular mechanisms. ([PubMed Central (PMC)](https://pmc.ncbi.nlm.nih.gov/articles/PMC4024116/?utm_source=chatgpt.com "Molecular basis of DEL phenotype in the Chinese population")) 26. **[Molecular and Computational Analysis of Weak-D and DEL Alleles in Northeastern China](https://pmc.ncbi.nlm.nih.gov/articles/PMC6880393/)** — Combines molecular testing and computational prediction to characterize D variants in a northeastern Chinese population, including highly prevalent RHD c.1227A-related states. ([PubMed Central (PMC)](https://pmc.ncbi.nlm.nih.gov/articles/PMC6880393/?utm_source=chatgpt.com "Molecular and computational analysis of 45 samples with a ...")) 27. **[Patients With Asian-Type DEL Can Safely Be Transfused With RhD-Positive Blood](https://pmc.ncbi.nlm.nih.gov/articles/PMC10273079/)** — Presents clinical and transcriptional evidence supporting the treatment of many people with complete Asian-type DEL as effectively D-positive for transfusion purposes, potentially conserving scarce D-negative units. ([PubMed Central (PMC)](https://pmc.ncbi.nlm.nih.gov/articles/PMC10273079/?utm_source=chatgpt.com "Patients with Asian-type DEL can safely be transfused ... - PMC")) 28. **[Asian-Type DEL With an Allo-Anti-D](https://pmc.ncbi.nlm.nih.gov/articles/PMC10528739/)** — Investigates a rare observation challenging the formerly absolute assumption that Asian-type DEL never produces allo-anti-D. The case reinforces the need to distinguish complete DEL from partial DEL and to investigate exceptional immunization histories carefully. ([PubMed Central (PMC)](https://pmc.ncbi.nlm.nih.gov/articles/PMC10528739/?utm_source=chatgpt.com "Asian-type DEL (RHD*DEL1) with an allo-anti-D - PMC - NIH")) 29. **[Forty Years of Researching the DEL Phenotype Results in a Change of Transfusion Practice](https://pmc.ncbi.nlm.nih.gov/articles/PMC11251845/)** — Reviews four decades of DEL research and the movement toward genotype-specific transfusion and obstetric management rather than treating every serologically D-negative person identically. ([PubMed Central (PMC)](https://pmc.ncbi.nlm.nih.gov/articles/PMC11251845/?utm_source=chatgpt.com "40 years of researching the Del phenotype results in a change ...")) 30. **[Does Transfusion of Asian-Type DEL Red Blood Cells to RhD-Negative Recipients Cause Anti-D Alloimmunization?](https://pmc.ncbi.nlm.nih.gov/articles/PMC6662620/)** — Examines the recipient-side risk of transfusing DEL-containing units and the distinction between managing DEL donors and managing DEL recipients. ([PubMed Central (PMC)](https://pmc.ncbi.nlm.nih.gov/articles/PMC6662620/?utm_source=chatgpt.com "Does transfusion of Asian-type DEL red blood cells to D - PMC")) --- ### Pregnancy, fetal RhD genotyping, and precision anti-D prophylaxis 31. **[Prevalence of RhD Status and Clinical Application of Non-Invasive Prenatal Determination of Fetal RHD](https://pmc.ncbi.nlm.nih.gov/articles/PMC4818414/)** — Reviews global differences in RhD-negative molecular mechanisms and evaluates maternal-plasma fetal RHD testing as a way to direct anti-D prophylaxis only to pregnancies carrying a genuinely D-positive fetus. ([PubMed Central (PMC)](https://pmc.ncbi.nlm.nih.gov/articles/PMC4818414/?utm_source=chatgpt.com "Prevalence of RhD status and clinical application of non ...")) 32. **[Determination of Fetal RHD Genotype Including the RHD Pseudogene in a Multiethnic Population](https://pmc.ncbi.nlm.nih.gov/articles/PMC6816963/)** — Demonstrates why fetal RHD assays must account for African-associated pseudogenes and variant alleles to avoid false-positive or indeterminate fetal calls. ([PubMed Central (PMC)](https://pmc.ncbi.nlm.nih.gov/articles/PMC6816963/?utm_source=chatgpt.com "Determination of Fetal RHD Genotype Including the ... - PMC")) 33. **[Integrating RHD Genotyping for More Accurate RhD-Antigen Classification and Pregnancy Management](https://pmc.ncbi.nlm.nih.gov/articles/PMC12028936/)** — A recent synthesis of genotype-guided classification, with particular attention to variant alleles in Black populations, partial D, weak D, and the prevention of avoidable alloimmunization. ([PubMed Central (PMC)](https://pmc.ncbi.nlm.nih.gov/articles/PMC12028936/?utm_source=chatgpt.com "Integrating RHD Genotyping for More Accurate Rh(D) Antigen ...")) --- ### Deep evolutionary history of ABO and the AB phenotype 34. **[The ABO Blood Group Is a Trans-Species Polymorphism in Primates](https://pubmed.ncbi.nlm.nih.gov/23091028/)** — Demonstrates that A- and B-like allelic classes have been maintained by balancing selection across distantly related primates for millions of years. This is the strongest scientific basis for describing the ABO distinction as deeply ancient—but not as evidence of an anomalous species origin. ([PubMed](https://pubmed.ncbi.nlm.nih.gov/23091028/?utm_source=chatgpt.com "The ABO blood group is a trans-species polymorphism in ...")) 35. **[Trans-Species Polymorphism in Humans and the Great Apes](https://pubmed.ncbi.nlm.nih.gov/26337052/)** — Places ABO within the wider class of ancient immune-related polymorphisms preserved across speciation boundaries by balancing selection. ([PubMed](https://pubmed.ncbi.nlm.nih.gov/26337052/?utm_source=chatgpt.com "Trans-species polymorphism in humans and the great ...")) 36. **[Relationship Between ABO Blood Group and von Willebrand Factor Levels: From Biology to Clinical Implications](https://pmc.ncbi.nlm.nih.gov/articles/PMC2042969/)** — Reviews the effect of ABO glycans on von Willebrand factor concentrations and clearance, providing the principal mechanistic bridge between ABO status and thrombosis-related epidemiology. ([PubMed Central (PMC)](https://pmc.ncbi.nlm.nih.gov/articles/PMC2042969/?utm_source=chatgpt.com "Relationship between ABO blood group and von Willebrand ...")) 37. **[The Relationship Between ABO Blood Group, von Willebrand Factor, and Primary Hemostasis](https://pmc.ncbi.nlm.nih.gov/articles/PMC7751360/)** — A more recent and technically detailed review showing that healthy group-O individuals generally have substantially lower VWF levels than non-O individuals and discussing glycosylation, proteolysis, clearance, and clinical interpretation. ([PubMed Central (PMC)](https://pmc.ncbi.nlm.nih.gov/articles/PMC7751360/?utm_source=chatgpt.com "The relationship between ABO blood group, von Willebrand ...")) 38. **[Non-O Blood Group: An Important Genetic Risk Factor for Venous Thromboembolism](https://pmc.ncbi.nlm.nih.gov/articles/PMC3626462/)** — Reviews the repeatedly observed association between non-O phenotypes—including AB—and elevated thrombotic risk, largely mediated through VWF and factor VIII biology. ([PubMed Central (PMC)](https://pmc.ncbi.nlm.nih.gov/articles/PMC3626462/?utm_source=chatgpt.com "Non-O blood group: an important genetic risk factor for venous ...")) 39. **[Is ABO Blood Group Truly a Risk Factor for Thrombosis and Adverse Outcomes?](https://pmc.ncbi.nlm.nih.gov/articles/PMC4176807/)** — A critical review of the strength, mechanisms, and limitations of ABO–thrombosis associations, useful for distinguishing reproducible physiological effects from overinterpreted blood-type claims. ([PubMed Central (PMC)](https://pmc.ncbi.nlm.nih.gov/articles/PMC4176807/?utm_source=chatgpt.com "Is ABO blood group truly a risk factor for thrombosis and ... - PMC")) 40. **[ABO Blood Groups and Cardiovascular Diseases](https://pmc.ncbi.nlm.nih.gov/articles/PMC3485501/)** — Summarizes epidemiological and molecular evidence connecting ABO status with coronary disease, ischemic events, endothelial adhesion, inflammation, VWF, and factor VIII. ([PubMed Central (PMC)](https://pmc.ncbi.nlm.nih.gov/articles/PMC3485501/?utm_source=chatgpt.com "ABO Blood Groups and Cardiovascular Diseases - PMC")) --- ### Large-scale disease associations and exploratory anomalies 41. **[Associations of ABO and Rhesus D Blood Groups With Phenome-Wide Disease Incidence: A 41-Year Study of 482,914 Patients](https://elifesciences.org/articles/83116)** — A nationwide Danish analysis testing 1,312 diagnostic phenotypes. It identified multiple statistically significant ABO and RhD associations, including a reproducible prothrombotic pattern for AB, while explicitly cautioning that the retrospective design cannot establish causation. ([eLife](https://elifesciences.org/articles/83116?utm_source=chatgpt.com "Associations of ABO and Rhesus D blood groups with ...")) 42. **[Negative Effects of Latent Toxoplasmosis on Mental Health](https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2019.01012/full)** — Part of the Czech research line examining latent _Toxoplasma gondii_, health, neurobehavior, and possible modification by RhD status. The paper is relevant as an exploratory anomaly source but relies heavily on observational and self-reported data and requires independent replication. ([Frontiers](https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2019.01012/full "Frontiers | Negative Effects of Latent Toxoplasmosis on Mental Health")) 43. **[ABO Blood Group Distributions in Multiple-Sclerosis Patients From the Basque Country](https://pmc.ncbi.nlm.nih.gov/articles/PMC6859684/)** — A regional study comparing ABO/Rh frequencies in a Basque multiple-sclerosis cohort with local donor data. It is hypothesis-generating rather than decisive but useful for geographically controlled disease-association work. ([PubMed Central (PMC)](https://pmc.ncbi.nlm.nih.gov/articles/PMC6859684/?utm_source=chatgpt.com "ABO blood group distributions in multiple sclerosis patients ...")) 44. **[Systematic Review and Meta-Analysis of ABO Blood Group, Factor V Leiden, and Venous Thromboembolism](https://pmc.ncbi.nlm.nih.gov/articles/PMC9406524/)** — Examines interaction between ABO status and inherited thrombophilia, including evidence that group AB may compound thrombotic risk in people who also carry Factor V Leiden. ([PubMed Central (PMC)](https://pmc.ncbi.nlm.nih.gov/articles/PMC9406524/?utm_source=chatgpt.com "Systematic Review and Meta-Analysis of the Susceptibility of ...")) --- ### Rh-null, RhAG, membrane integrity, and the physiological function of Rh proteins 45. **[RH Blood Group System and Molecular Basis of Rh Deficiency](https://pubmed.ncbi.nlm.nih.gov/10895258/)** — A foundational account of the Rh-null and Rh-mod syndromes, showing that the Rh/RhAG complex contributes to membrane organization, cell shape, cation transport, phospholipid arrangement, and red-cell survival. ([PubMed](https://pubmed.ncbi.nlm.nih.gov/10895258/?utm_source=chatgpt.com "RH blood group system and molecular basis of Rh-deficiency - PubMed")) 46. **[Rhnull Phenotype Caused by a Novel RHAG Mutation, c.945+1G>A, in the Japanese Population](https://pubmed.ncbi.nlm.nih.gov/30990901/)** — Reports a Japanese regulator-type Rh-null phenotype caused by a splice-site mutation in RHAG, linking total Rh-antigen absence with chronic hemolytic anemia. ([Niigata University Researchers Directory](https://researchers.adm.niigata-u.ac.jp/html/200002043_ja.html?utm_source=chatgpt.com "研究者詳細 - 片桐　隆幸")) 47. **[A Novel c.790C>T Mutation in RHAG Encoding the Rhnull Phenotype in a Japanese Family](https://onlinelibrary.wiley.com/doi/abs/10.1111/voxs.12238)** — A Japanese Red Cross family study identifying another RHAG mechanism for regulator-type Rh-null blood. ([Wiley Online Library](https://onlinelibrary.wiley.com/doi/abs/10.1111/voxs.12238?utm_source=chatgpt.com "A novel c.790C>T mutation in RHAG gene encoding the Rhnull phenotype in Japanese - Tanaka - 2016 - ISBT Science Series - Wiley Online Library")) 48. **[Molecular Approaches to the Rh Blood Group System](https://pubmed.ncbi.nlm.nih.gov/17134012/)** — Japanese review emphasizing differences among European RHD deletion, Japanese RHD-retaining negative phenotypes, and RHAG-associated Rh-null states. ([PubMed](https://pubmed.ncbi.nlm.nih.gov/17134012/?utm_source=chatgpt.com "[Molecular approaches to the Rh blood group system] - PubMed")) 49. **[Hematological Aspects of Rh-Deficiency Syndrome: A Case Report and Review](https://pubmed.ncbi.nlm.nih.gov/3103426/)** — Reviews anemia, stomatocytosis, reticulocytosis, shortened red-cell survival, splenectomy outcomes, and the hematological phenotype of Rh-null and Rh-mod individuals. ([PubMed](https://pubmed.ncbi.nlm.nih.gov/3103426/?utm_source=chatgpt.com "Hematological aspect of Rh deficiency syndrome: a case report and a review of the literature - PubMed")) --- ### Engineered universal and antigen-minimized blood 50. **[_Akkermansia muciniphila_ Exoglycosidases Target Extended Blood-Group Antigens to Generate ABO-Universal Blood](https://www.nature.com/articles/s41564-024-01663-4)** — Danish–Swedish work identifying gut-bacterial enzyme combinations capable of removing not only canonical A and B antigens but also extended glycan structures that had frustrated earlier blood-conversion attempts. ([Nature](https://www.nature.com/articles/s41564-024-01663-4?utm_source=chatgpt.com "Akkermansia muciniphila exoglycosidases target extended ...")) 51. **[CRISPR-Cas9-Driven Antigen Conversion of Clinically Relevant Blood-Group Systems](https://academic.oup.com/hmg/article/34/12/1001/8103850)** — Demonstrates gene-editing strategies for altering clinically important blood-group antigens in cultured erythroid systems, advancing the possibility of rare-phenotype-compatible manufactured blood. ([OUP Academic](https://academic.oup.com/hmg/article/34/12/1001/8103850?utm_source=chatgpt.com "CRISPR-Cas9-driven antigen conversion of clinically relevant ...")) 52. **[Genome-Edited Peripheral-Blood Stem-Cell-Derived Erythroid Progenitor Cells as Panel Cells for Antibody Identification](https://haematologica.org/article/view/12021)** — Japanese researchers deleted major antigens from the Rh, Duffy, P1PK, Kidd, JR, and MNS systems while retaining erythroid proliferation and differentiation. ([Haematologica](https://haematologica.org/article/view/12021?utm_source=chatgpt.com "Genome-edited peripheral blood stem cell-derived ...")) 53. **[Genome-Edited Erythroid Precursor Cells Lacking Eleven Blood-Group Antigens](https://www.jstage.jst.go.jp/article/jjtc/72/1/72_94/_pdf)** — Japanese-language 2026 report describing deletion of RhD, RhC/e, M/N/s, P1, Fya, Jka/Jkb, and Jra antigens from cultured erythroid cells. It is one of the clearest current demonstrations of **modular blood-group engineering**. ([J-STAGE](https://www.jstage.jst.go.jp/article/jjtc/72/1/72_94/_pdf?utm_source=chatgpt.com "ゲノム編集された末梢血幹細胞由来赤血球前駆細胞株は ...")) 54. **[Tailor-Made Red Cells: The Long Road Toward Blood Safety](https://haematologica.org/article/view/12089)** — Editorial assessment of the scientific and manufacturing obstacles separating laboratory antigen-edited erythroid cells from scalable, mature, transfusion-ready red cells. ([Haematologica](https://haematologica.org/article/view/12089?utm_source=chatgpt.com "Tailor-made red cells: the long road towards blood safety")) --- ### AB-negative prevalence, compatibility, plasma value, and donor operations 55. **[AB-Negative Blood Type—NHS Blood and Transplant](https://www.blood.co.uk/why-give-blood/blood-types/ab-negative-blood-type/)** — Current UK donor information describing AB-negative as approximately **1% of donors**, its limited red-cell recipient population, and the ability of AB-negative recipients to receive red cells from any ABO group provided they are RhD-negative. ([NHS Blood Donation](https://www.blood.co.uk/why-give-blood/blood-types/ab-negative-blood-type/?utm_source=chatgpt.com "AB negative blood type - NHS Blood Donation")) 56. **[Blood-Type Frequencies—NHS Blood and Transplant](https://www.blood.co.uk/why-give-blood/blood-types/)** — February 2026 UK donor distribution data across the eight conventional ABO/RhD categories. Useful for distinguishing donor-population frequency from general-population or global frequency. ([NHS Blood Donation](https://www.blood.co.uk/why-give-blood/blood-types/?utm_source=chatgpt.com "Blood types - NHS Blood Donation")) 57. **[AB Negative—Sanquin, Netherlands](https://www.sanquin.nl/en/donors/about-blood/blood-types/ab-negative)** — Reports that approximately **0.5% of the Dutch population** is AB-negative and explains why donation demand depends on component and inventory needs rather than rarity alone. ([Sanquin](https://www.sanquin.nl/en/donors/about-blood/blood-types/ab-negative?utm_source=chatgpt.com "AB negative | Sanquin")) 58. **[AB-Negative Compatibility and Frequency—Sanquin](https://www.sanquin.nl/donors/alles-over-bloed/bloedgroepen/bloedgroep-ab-negatief)** — Dutch-language compatibility reference specifying the red-cell donor and recipient relationships for AB-negative blood. ([Sanquin](https://www.sanquin.nl/donors/alles-over-bloed/bloedgroepen/bloedgroep-ab-negatief?utm_source=chatgpt.com "Bloedgroep AB-negatief | Sanquin")) 59. **[French Blood Donor Guide—Établissement français du sang](https://dondesang.efs.sante.fr/sites/default/files/2025-01/GuideDuDonneur-EFS-DocsUsuels-2025-BD.pdf)** — Official French guide emphasizing that group-AB plasma is broadly compatible because it lacks anti-A and anti-B, making the relatively small AB donor population especially valuable for plasma collection. ([Etablissement francais du sang](https://dondesang.efs.sante.fr/sites/default/files/2025-01/GuideDuDonneur-EFS-DocsUsuels-2025-BD.pdf?utm_source=chatgpt.com "LE GUIDE DU")) 60. **[Plasma Donation and Universal AB Plasma—Établissement français du sang](https://dondesang.efs.sante.fr/sites/default/files/2022-04/D%C3%A9pliant_Plasma_BD_0.pdf)** — French-language component-donation reference explaining the reversed compatibility logic of plasma and the exceptional operational value of AB plasma. ([Etablissement francais du sang](https://dondesang.efs.sante.fr/sites/default/files/2022-04/D%C3%A9pliant_Plasma_BD_0.pdf?utm_source=chatgpt.com "COMME POUR LE DON DE SANG,")) Taken together, these sources support a more precise research ontology in which **AB Rh-negative is not a unitary biological lineage but a composite phenotype** produced by an ancient ABO glycan polymorphism and one of several possible RHD-expression states. The most productive frontier lies in **full RH haplotyping, DEL and partial-D resolution, ancestry-aware molecular diagnostics, antigen-density measurement, fetal cell-free DNA analysis, and programmable antigen-minimized erythrocytes**.